Literature DB >> 16973543

Optimization of feline immunodeficiency virus vectors for RNA interference.

Scott Q Harper1, Patrick D Staber, Christine R Beck, Sarah K Fineberg, Colleen Stein, Dalyz Ochoa, Beverly L Davidson.   

Abstract

RNA interference (RNAi) occurs naturally in plant and animal cells as a means for modulating gene expression. This process has been experimentally manipulated to achieve targeted gene silencing in cells, tissues, and animals, using a variety of vector systems. Here, we tested the hypothesis that vectors based on feline immunodeficiency virus (FIV) could be used for coexpression of reporter constructs and RNAi expression cassettes. We found, unexpectedly, in our initial constructs that placement of RNAi expression cassettes downstream from a polymerase II (pol II)-expressed reporter gene inhibited reporter expression but not vector titer. Through a series of intermediate vector constructs, we found that placement of the RNAi expression cassette relative to the Rev response element and the pol II expression cassette was critical for efficient RNAi and reporter gene expression. These results suggested that steric factors, including RNA structure and recruitment of competing transcriptional machinery, may affect gene expression from FIV vectors. In a second series of studies, we show that target sequence silencing can be achieved in cells transduced by FIV vectors coexpressing reporter genes and 3' untranslated region resident microRNAs. The optimized FIV-based RNAi expression vectors will find broad use given the extensive tropism of pseudotyped FIV vectors for many cell types in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973543      PMCID: PMC1617215          DOI: 10.1128/JVI.00958-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.

Authors:  Makoto Miyagishi; Hidetoshi Sumimoto; Hiroyuki Miyoshi; Yutaka Kawakami; Kazunari Taira
Journal:  J Gene Med       Date:  2004-07       Impact factor: 4.565

2.  A common octamer motif binding protein is involved in the transcription of U6 snRNA by RNA polymerase III and U2 snRNA by RNA polymerase II.

Authors:  P Carbon; S Murgo; J P Ebel; A Krol; G Tebb; L W Mattaj
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

3.  Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.

Authors:  J C Johnston; M Gasmi; L E Lim; J H Elder; J K Yee; D J Jolly; K P Campbell; B L Davidson; S L Sauter
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors.

Authors:  E M Poeschla; F Wong-Staal; D J Looney
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

5.  Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.

Authors:  Hidetoshi Sumimoto; Makoto Miyagishi; Hiroyuki Miyoshi; Shizuko Yamagata; Ayako Shimizu; Kazunari Taira; Yutaka Kawakami
Journal:  Oncogene       Date:  2004-08-12       Impact factor: 9.867

6.  Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells.

Authors:  Zhi Wang; Lili Ren; Xingang Zhao; Tao Hung; Anming Meng; Jianwei Wang; Ye-Guang Chen
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.

Authors:  F J Thompson; J Elder; J C Neil
Journal:  J Gen Virol       Date:  1994-03       Impact factor: 3.891

8.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

9.  Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.

Authors:  E E Sparger; B L Shacklett; L Renshaw-Gegg; P A Barry; N C Pedersen; J H Elder; P A Luciw
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

10.  Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors.

Authors:  Antonella Consiglio; Angela Gritti; Diego Dolcetta; Antonia Follenzi; Claudio Bordignon; Fred H Gage; Angelo Luigi Vescovi; Luigi Naldini
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-04       Impact factor: 11.205

View more
  8 in total

1.  RNA interference improves myopathic phenotypes in mice over-expressing FSHD region gene 1 (FRG1).

Authors:  Lindsay M Wallace; Sara E Garwick-Coppens; Rossella Tupler; Scott Q Harper
Journal:  Mol Ther       Date:  2011-07-05       Impact factor: 11.454

Review 2.  Recent advances in RNA interference therapeutics for CNS diseases.

Authors:  Pavitra S Ramachandran; Megan S Keiser; Beverly L Davidson
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

Review 3.  Human gene therapy vectors derived from feline lentiviruses.

Authors:  Román A Barraza; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

4.  Molecular characterization of feline immunodeficiency virus budding.

Authors:  Benjamin G Luttge; Miranda Shehu-Xhilaga; Dimiter G Demirov; Catherine S Adamson; Ferri Soheilian; Kunio Nagashima; Andrew G Stephen; Robert J Fisher; Eric O Freed
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

5.  Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism.

Authors:  Douglas E Dylla; Litao Xie; Daniel E Michele; Stefan Kunz; Paul B McCray
Journal:  Genet Vaccines Ther       Date:  2011-04-08

6.  Construction of permanently inducible miRNA-based expression vectors using site-specific recombinases.

Authors:  Sara E Garwick-Coppens; Adam Herman; Scott Q Harper
Journal:  BMC Biotechnol       Date:  2011-11-16       Impact factor: 2.563

7.  MiR-34a represses Numbl in murine neural progenitor cells and antagonizes neuronal differentiation.

Authors:  Sarah K Fineberg; Poppy Datta; Colleen S Stein; Beverly L Davidson
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

Review 8.  Current prospects for RNA interference-based therapies.

Authors:  Beverly L Davidson; Paul B McCray
Journal:  Nat Rev Genet       Date:  2011-05       Impact factor: 53.242

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.